eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | rheumatoid arthritis |
| Comorbidity | C0699893|nonmelanoma skin cancer |
| Sentences | 1 |
| PubMedID- 22382344 | Objective: to assess the risk of total malignancy and nonmelanoma skin cancers (nmsc) in patients with rheumatoid arthritis (ra) receiving certolizumab and golimumab through a metaanalysis of data from randomized control trials (rct). |
Page: 1